Abstract:Introduction: Corin is a protease in the natriuretic peptide system. Deleterious CORIN variants are associated with hypertension and heart disease. It remains unclear if and to what extent corin deficiency may contribute to heart failure (HF). Methods: Corin knockout (KO) mice were used as a model. Cardiac function was assessed by echocardiography and tissue analysis in Corin KO mice at different ages or subjected to transverse aortic constriction (TAC), which increased pressure overload. Heart and lung tissues were analyzed for cardiac hypertrophy and lung edema using wheat germ agglutinin, Sirius red, Masson's trichrome, and Prussian blue staining. Recombinant corin was tested for its effect on cardiac function in the TAC-operated Corin KO mice. Selected gene expression in the heart was examined by RT-PCR. ELISA was used to analyze factors in plasma. Results: Corin KO mice had progressive cardiac dysfunction with cardiac hypertrophy and fibrosis after 9 months of age, likely due to chronic hypertension. When Corin KO mice were subjected to TAC at 10–12 weeks of age, cardiac function decreased more rapidly than in similarly treated wild-type mice. When the TAC-operated Corin KO mice were treated with recombinant corin protein, cardiac dysfunction, hypertrophy, and fibrosis were ameliorated. The corin treatment also decreased the gene expression associated with cardiac hypertrophy and fibrosis, increased plasma cGMP levels, lowered plasma levels of N-terminal pro-atrial natriuretic peptide, angiotensin II, and aldosterone, and lessened lung edema in the Corin KO mice subjected to TAC. Conclusion: Corin deficiency impairs cardiac function and exacerbates HF development in mice. Corin protein may be used to reduce cardiac hypertrophy and fibrosis, suppress the renin-angiotensin-aldosterone system, and improve cardiac function in HF.

Upregulation of Corin Gene Expression in Hypertrophic Cardiomyocytes and Failing Myocardium

Protease corin expression and activity in failing hearts.

Corin: A Key Mediator in Sodium Homeostasis, Vascular Remodeling, and Heart Failure

Recombinant Soluble Corin Improves Cardiac Function in Mouse Models of Heart Failure

Corin deficiency impairs cardiac function in mouse models of heart failure

Processing of Pro-atrial Natriuretic Peptide by Corin in Cardiac Myocytes

Function and Regulation of Corin in Physiology and Disease.

Corin Variant Associated With Hypertension And Cardiac Hypertrophy Exhibits Impaired Zymogen Activation And Natriuretic Peptide Processing Activity

Corin, a Transmembrane Cardiac Serine Protease, Acts As a Pro-Atrial Natriuretic Peptide-Converting Enzyme.

Hypertension In Mice Lacking The Proatrial Natriuretic Peptide Convertase Corin

Corin in Natriuretic Peptide Processing and Hypertension

Corin: new insights into the natriuretic peptide system.

Corin in Clinical Laboratory Diagnostics

The Serine Protease Corin in Cardiovascular Biology and Disease

Corin is highly expressed in atherosclerosis models.

Role of corin in the regulation of blood pressure.

Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy

Localization of Corin and Atrial Natriuretic Peptide Expression in Human Renal Segments

Corin-mediated Processing of Pro-Atrial Natriuretic Peptide in Human Small Cell Lung Cancer Cells.

Retracted: the Correlation Between Angiogenesis and Abnormal Expression of SERCA2a, Phospholamban and the Endothelin Pathway in Heart Failure, and Improvement by Puerarin

Plasma Soluble Corin in Patients with Heart Failure.